Navigation Links
As Europe Regulates Probiotics, Americans Need to Know What They're Buying
Date:11/19/2010

BOULDER, Colo., Nov. 19, 2010 /PRNewswire/ -- With the European Union poised to regulate probiotics, and with probiotic supplement sales increasing dramatically in the United States, Americans need to know what they're buying, and how these products can affect their health.

"Currently, there are not these types of regulations in the U.S. As European regulations raise the bar in the probiotic industry world wide, U.S. consumers are still faced with a confusing array of immune system supplements, ingredients and health benefits claims," said Russian-trained microbiologist Dr. Liubov Shynkarenko, a veteran of Soviet Cold War-era bio-chemical warfare research that led to the development of modern probiotics as immune system supplements. "From moderate health imbalances to serious illnesses, different strains and combinations of probiotics will produce different results with liver, heart and other body systems affected by toxicity."

Now Vice President of Research for the Del-Immune V® probiotic product line, Dr. Shynkarenko recommends the following tips for consumers looking to achieve the most effective results from immune system supplements:

  • There are varieties of probiotic strains that can have different effects on each individual. Schedule a micro flora profile with your family health physician or health professional to identify the best kind of probiotic to take based on the specific kinds of bacteria that differ in everyone's body. These strains and combinations efficacy and specificity are what the European Union will be regulating through clinical trials.

  • To ensure that the product you are taking includes live cultures, look at the ingredients. The most popular strains of probiotics today belong to Lactobacillus and Bifidobacterium families. Often, they are only identified on the label by their first initial such as L. or B. Your doctor can help you identify the correct strain for your body and condition.

  • Confirm that it is a legitimate company with a credible website, backed up with extensive research and scientific articles on the products as well as testimonials from customers and healthcare providers.

"With Europe and eventually the U.S. conducting trials and regulating the probiotics industry, better products will be developed, and consumers will have access to more information," said Dr. Shynkarenko. "This will lead to better understanding, and give doctors the knowledge they need to advise patients on the proper strains and combinations of probiotic supplements, which will vary between individuals."

About Del-Immune

Del-Immune V®, manufactured by Lyoferm Inc. in Indiana and distributed by Boulder-based Pure Research Products LLC (PRP), is a probiotic-derived nutritional supplement that provides immediate immune system support. Del-Immune represents the culmination of 30 years of research originated by Cold War-era Soviet Bloc scientists and Russian military bio-warfare troop protection programs. PRP obtained exclusive rights to manufacture, distribute and market the unique Lactobacillus rhamnosus (DV strain) from its Russian partners in 2002. Del-Immune V is used by thousands and recommended by doctors around the world. For more information, please visit http://www.del-immune.com.

Contact:
Jill Thompson
720-833-5921
jthompson@metzger.com



This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE Pure Research Products, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. The European Medicines Agency Validates and Accepts Cell Therapeutics Marketing Authorization Application for Pixuvri™
2. Reportlinker Adds European Markets for Wound and Tissue Management 2011
3. Blue Medical Receives European CE Mark Approvals for Drug Eluting Balloon and Stent on Drug Eluting Balloon Combination Device
4. SRI International Executive Walter Moos to Discuss Collaborative Pharmaceutical Opportunities with a Nonprofit Organization at BIO-Europe 2010
5. Celsion Receives COMP Recommendation for Orphan Drug Designation in Europe for ThermoDox® to Treat Primary Liver Cancer
6. European PACS Market To Attain $512M by 2015
7. Kensey Nash and Arthrex Announce European Distribution Agreement for the Cartilage Repair Device
8. PAREXEL Expert to Lead Track on Global Clinical Outsourcing at Partnerships in Clinical Trials Europe Conference
9. Biosimilar Erosion of Branded ESA Market Share Will be More Rapid in the U.S. Than in Europe
10. Reprints Desk to Highlight New Solution for Scientific, Technical, and Medical Research at Pharma-Bio-Med Conference and Exposition in Europe
11. Drug-Coated Balloons Slowly Making Their Mark on the European Interventional Cardiology Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ANGELES , Dec. 8, 2016  Hanson ... manufacturing of dissolution testing and diffusion testing instruments ... been acquired by Teledyne Instruments, Inc. ("Teledyne"). The ... long-proven line of precision testing instruments, as well ... accelerating development of new products and services. ...
(Date:12/8/2016)... 2016  Haemonetics Corporation (NYSE: HAE ) has ... an innovative software suite designed to help customers drive efficiency ... of NextGen DMS 4 improves core features and introduces innovations ... liter of plasma collected, enhancing quality and regulatory compliance and ... ...
(Date:12/8/2016)... Inc . has announced regulatory approval by CFDA and product launch in ... (GERD). Continue Reading ... ... by Professor Jun Liu, Director of Endoscopy at Wuhan Union Hospital ... "We are very pleased that Mederi products are now available in ...
Breaking Medicine Technology:
(Date:12/8/2016)... PLAINS, N.Y., and JENNERSVILLE, Pa. (PRWEB) , ... ... ... to announce that Penn Medicine Southern Chester County, a Property owned by an ... The $23 million, 72,000 square foot Penn Medicine Southern Chester County ambulatory care ...
(Date:12/8/2016)... Boston (PRWEB) , ... December 08, 2016 , ... ... shareholders with global law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. ... sponsor of the DeviceTalks series, and attorneys from the firm’s global Life Sciences & ...
(Date:12/8/2016)... N.J. (PRWEB) , ... December 08, 2016 , ... ... delivery technologies and development solutions for drugs, biologics and consumer health products, today ... PSCI was set up in 2006 as a non-profit organization to unite pharmaceutical ...
(Date:12/8/2016)... Peachtree City, Ga (PRWEB) , ... December 08, ... ... and moving as soon after surgery as possible. With this in mind, SIGVARIS ... vein thrombosis (DVT or blood clot) during bed rest and provide the benefits ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... services from offices headquartered in Hamilton County, is embarking on a charity drive ... specializes in finding new homes for orphaned or neglected senior dogs in the ...
Breaking Medicine News(10 mins):